$31.74 B
๐Ÿ‡ฐ๐Ÿ‡ท South Korea
Share price
Change (1 day)
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Market capitalization of Celltrion (068270.KS)

Market cap: $31.74 Billion

As of September 2021 Celltrion has a market cap of $31.74 Billion. This makes Celltrion the world's 628th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.

Market cap history of Celltrion from 2007 to 2021

Year Market cap Change
2021$31.94 B-22.7%
2020$41.32 B112.77%
2019$19.42 B-16.95%
2018$23.38 B0.71%
2017$23.22 B110.1%
2016$11.05 B37.92%
2015$8.01 B139.49%
2014$3.34 B5.48%
2013$3.17 B-16.63%
2012$3.80 B6.92%
2011$3.55 B8.58%
2010$3.27 B155.96%
2009$1.28 B51.52%
2008$0.84 B5689.26%
2007$0.01 B